Austin Harris MD Introduces Personalized Ketamine Therapy with 85% Success Rate in Los Angeles
March 3rd, 2026 8:00 AM
By: Newsworthy Staff
Dr. Austin Harris is transforming mental health and chronic pain treatment through personalized IV ketamine therapy combined with integrative care, achieving an 85% success rate for conditions including depression, anxiety, and PTSD.

Dr. Austin Harris, founder and medical director of NeuroRelief Ketamine & Infusion Therapy, is bringing transformative mental health and chronic pain treatment to Los Angeles through innovative IV ketamine therapy combined with comprehensive integrative care. With over 12 years of specialized experience in ketamine treatment and a background as a board-certified cardiothoracic anesthesiologist, Dr. Harris has developed a uniquely personalized approach that has achieved an 85% success rate in treating depression, anxiety, PTSD, migraines, chronic pain syndromes, and substance abuse recovery.
What distinguishes NeuroRelief from conventional treatment centers is its "one-size-fits-one" philosophy. Dr. Harris and his team develop fully customized programs for each client, integrating IV ketamine therapy with NAD+ infusion therapy and micronutrient infusions. Each treatment plan is tailored to the individual's unique neurology, psychology, personality, physiology, and specific goals. The practice offers what Dr. Harris calls "fully integrated" care, meaning every patient works one-on-one with professionals who provide training, guidance, and support in implementing sustainable healing practices.
This comprehensive approach includes mindfulness meditation, mindful cognitive behavioral therapy exercises, and certified integration and recovery coaching. In an unprecedented commitment to patient care, Dr. Harris provides all patients with seven-day-a-week real-time access to his personal cell phone, serving as a continuous guide and support system throughout their transformative healing journey. "EVERY single person deserves the right to find relief," says Dr. Harris. "Our mission is to provide hope and healing to individuals who have struggled to find effective treatment through traditional approaches."
Dr. Harris earned his Doctor of Medicine degree, Magna Cum Laude, from St. George's University School of Medicine. He completed his anesthesiology residency at the University of California Irvine and a fellowship in cardiothoracic anesthesiology at the Keck School of Medicine, USC. He is also certified in Psychedelic Integration Therapy and Psychedelic-Assisted Psychotherapy through Fluence. With over a decade of experience in cardiac, thoracic, general, and pediatric anesthesiology, Dr. Harris has served as an attending anesthesiologist at major hospitals across Los Angeles.
He is a frequent speaker at national psychedelic medicine and ketamine therapy conferences and has become a leading advocate for the safe, effective, and compassionate use of ketamine in modern medicine. Dr. Harris's approach combines his extensive medical expertise with a deep commitment to integrative healing modalities. His work encompasses advanced cardiac and thoracic anesthesia, perioperative echocardiography, critical care, and integrative approaches to trauma, addiction, and mood disorders.
Beyond his clinical practice, Dr. Harris is passionate about psychedelic science and the future of mental health care, mind-body medicine, and supporting veterans and underserved communities through pro bono medical care. He remains dedicated to educating the public on the safe, ethical use of psychedelic therapies. NeuroRelief Ketamine & Infusion Therapy, founded in August 2019, offers innovative treatment strategies for patients seeking assistance with mental health challenges, chronic pain, and substance abuse recovery.
Source Statement
This news article relied primarily on a press release disributed by 24-7 Press Release. You can read the source press release here,
